Houston Shock Symposium

About
Us

An exciting, 2.5 day event that attracts world renowned experts in the field of shock to discuss current topics, challenging cases, share their expertise, and advance knowledge to a broad audience of providers.

Together, we can reduce shock's high mortality rate

The Houston Shock Symposium brings together world-renowned experts to share knowledge, discuss challenging cases, and advance shock management for a broad audience of healthcare providers. This year, we invite you to join us April 3–5, 2025, for an exciting 2.5-day event in the heart of downtown Houston.

Event highlights:

Free general registration with complimentary breakfast and lunch provided.
130+ national and international experts leading discussions on current topics and innovative approaches to shock care.
Networking opportunities with 2,500+ registrants from around the globe.
Earn continuing education credits in medical, nursing, ASRT, ABIM MOC, and perfusion.*
Get hands-on training in percutaneous MCS device support, large bore access and closure, and the latest therapeutic devices at our Shock Arena and Shock Experiences tables.
Integrated RN and APP-focused content in every session, emphasizing a multidisciplinary, team-based approach to reducing shock’s high mortality rate.
Two games of Shock Jeopardy where participants test their knowledge, compete with peers, and enhance their understanding of shock-related topics.

Together, we’re building a community dedicated to learning, collaboration, and saving lives. Don’t miss this opportunity to connect with leading experts, gain hands-on experience, and expand your knowledge in shock management. Register today to attend #HSS25!

Target
Audience

This symposium is designed for:

Cardiologists
Advanced heart failure cardiologists
Cardiothoracic surgeons
Intensivists and critical care physicians
Nurses
Perfusionists
Residents/fellows
Advanced practice providers
Medical staff interested in the physiology, diagnosis, and management of shock

Learning Objectives

Upon completion of this activity, participants should be able to:

Explain that cardiogenic shock is a final common pathway of multiple different disease states, and that management should be implemented early, and efficiently.
Define best practices in management of shock and the optimal timing and utilization of percutaneous circulatory assist device including counter-pulsation, left ventricular, right ventricular, or biventricular support device for different shock cases.
Identify cardiogenic shock research priorities, to conduct clinical trials, and to create large population-based registries to generate quality improvement opportunities.
Discuss current clinical evidence on management of post LVAD and transplant shock and outline best practices of high-volume centers from a surgical and medical perspective.
Describe the kinetics of cardiogenic shock and patient-device interaction as well as non-device therapeutic options for treatment including hypothermia, revascularization, and inotropes.
Describe the impact of pulmonary embolism (PE) and therapies available for hemodynamically unstable PE, including mechanical circulatory support device therapy for stabilization.
Review management strategies for the critically ill in medical ICU, such as ARDS management
Discuss current and future therapies for valvular heart disease.